Skip to Content

What is the difference between Soliqua and Xultophy?

Answers (1)

Official Answer by 30 Nov 2016

Soliqua 100/33 is Sanofi’s once-daily injection used alongside diet and exercise to improve blood sugar control in type 2 diabetes.

Soliqua 100/33 is a combination of insulin glargine 100 Units/mL (Lantus) and lixisenatide 33 mcg/mL (Adlyxin), a glucagon-like peptide-1 (GLP-1) agonist, for patients inadequately controlled on basal insulin (less than 60 units daily) or lixisenatide.

Xultophy 100/3.6 is Novo Nordisk’s once-daily injection of insulin degludec (Tresiba), and the GLP-1 agonist liraglutide (Victoza), also used to treat type 2 diabetes.

Xultophy is used in adults inadequately controlled on less than 50 units of basal insulin daily or less than or equal to 1.8 mg of liraglutide daily.

These two medications are the first approved in a novel group of diabetes treatments that combine a long-acting insulin with a GLP-1 agonist.

Votes: +0 free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What are the active ingredients in Qtern?

Posted 5 Jul 2017 1 answerFAQ by

What is the Siliq REMS Program?

Posted 5 Jul 2017 1 answerFAQ by

What type of drug is Emflaza?

Posted 5 Jul 2017 1 answerFAQ by

What is Parsabiv used to treat?

Posted 5 Jul 2017 1 answerFAQ by

Is Xyzal available over-the-counter?

Posted 5 Jul 2017 1 answerFAQ by